139 related articles for article (PubMed ID: 33122771)
1. Subcellular localization of HMGB1 in colorectal cancer impacts on tumor grade and survival prognosis.
Wang CQ; Huang BF; Wang Y; Tang CH; Jin HC; Shao F; Shao JK; Wang Q; Zeng Y
Sci Rep; 2020 Oct; 10(1):18587. PubMed ID: 33122771
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma.
Yao X; Zhao G; Yang H; Hong X; Bie L; Liu G
J Cancer Res Clin Oncol; 2010 May; 136(5):677-84. PubMed ID: 19898867
[TBL] [Abstract][Full Text] [Related]
3. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
Qian F; Xiao J; Gai L; Zhu J
Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
[TBL] [Abstract][Full Text] [Related]
4. Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer.
Zhang Z; Wang M; Zhou L; Feng X; Cheng J; Yu Y; Gong Y; Zhu Y; Li C; Tian L; Huang Q
J Exp Clin Cancer Res; 2015 May; 34(1):51. PubMed ID: 25986235
[TBL] [Abstract][Full Text] [Related]
5. Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
Huang M; Geng Y; Deng Q; Li R; Shao X; Zhang Z; Xu W; Wu Y; Ma Q
Int J Oncol; 2018 Oct; 53(4):1481-1492. PubMed ID: 30066846
[TBL] [Abstract][Full Text] [Related]
6. [The expression and significance of IGF1R-Ras/RAGE-HMGB1 pathway in colorectal cancer patients with type 2 diabetes mellitus].
Niu S; Zhao ZG; Lyu XM; Zhao M; Wang XZ; Liu WN; Zhao W; Zhang XH; Wang Y
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):391-395. PubMed ID: 32482028
[No Abstract] [Full Text] [Related]
7. Prognostic significance of high mobility group box 1 (HMGB1) expression in patients with colorectal cancer.
Ueda M; Takahashi Y; Shinden Y; Sakimura S; Hirata H; Uchi R; Takano Y; Kurashige J; Iguchi T; Eguchi H; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Anticancer Res; 2014 Oct; 34(10):5357-62. PubMed ID: 25275029
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.
Hongo K; Kazama S; Tsuno NH; Ishihara S; Sunami E; Kitayama J; Watanabe T
World J Surg Oncol; 2015 Jan; 13():7. PubMed ID: 25622595
[TBL] [Abstract][Full Text] [Related]
9. High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer.
Liao WT; Liu JL; Wang ZG; Cui YM; Shi L; Li TT; Zhao XH; Chen XT; Ding YQ; Song LB
BMC Gastroenterol; 2013 Aug; 13():126. PubMed ID: 23937454
[TBL] [Abstract][Full Text] [Related]
10. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
11. Loss of H2Bub1 Expression is Linked to Poor Prognosis in Nodal Negative Colorectal Cancers.
Melling N; Grimm N; Simon R; Stahl P; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
Pathol Oncol Res; 2016 Jan; 22(1):95-102. PubMed ID: 26347467
[TBL] [Abstract][Full Text] [Related]
12. [Expression of high mobility group box-1 in colorectal cancer and its clinical significance].
Li Z; Wang H; Song B; Sun Y; Han J; Xu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Jun; 18(6):616-9. PubMed ID: 26108781
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer.
Peng RQ; Wu XJ; Ding Y; Li CY; Yu XJ; Zhang X; Pan ZZ; Wan DS; Zheng LM; Zeng YX; Zhang XS
BMC Cancer; 2010 Sep; 10():496. PubMed ID: 20846416
[TBL] [Abstract][Full Text] [Related]
14. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
Wang L; Lin D; Fu Y; Lai M
Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic Pin1 expression is correlated with poor prognosis in colorectal cancer.
Pyo JS; Son BK; Oh IH
Pathol Res Pract; 2018 Nov; 214(11):1848-1853. PubMed ID: 30244946
[TBL] [Abstract][Full Text] [Related]
16. High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer.
Mei H; Lian S; Zhang S; Wang W; Mao Q; Wang H
Biochem Biophys Res Commun; 2014 Oct; 453(4):703-9. PubMed ID: 25301559
[TBL] [Abstract][Full Text] [Related]
17. The role of high mobility group box 1 (HMGB1) in colorectal cancer.
Süren D; Yıldırım M; Demirpençe Ö; Kaya V; Alikanoğlu AS; Bülbüller N; Yıldız M; Sezer C
Med Sci Monit; 2014 Mar; 20():530-7. PubMed ID: 24681824
[TBL] [Abstract][Full Text] [Related]
18. Subcellular Epithelial HMGB1 Expression Is Associated with Colorectal Neoplastic Progression, Male Sex, Mismatch Repair Protein Expression, Lymph Node Positivity, and an 'Immune Cold' Phenotype Associated with Poor Survival.
Porter RJ; Murray GI; Hapca S; Hay A; Craig SG; Humphries MP; James JA; Salto-Tellez M; Brice DP; Berry SH; McLean MH
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980751
[TBL] [Abstract][Full Text] [Related]
19. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.
Wang XQ; Tang ZX; Yu D; Cui SJ; Jiang YH; Zhang Q; Wang J; Yang PY; Liu F
Oncotarget; 2016 Feb; 7(8):8823-38. PubMed ID: 26741506
[TBL] [Abstract][Full Text] [Related]
20. Direct molecular interactions between HMGB1 and TP53 in colorectal cancer.
Livesey KM; Kang R; Zeh HJ; Lotze MT; Tang D
Autophagy; 2012 May; 8(5):846-8. PubMed ID: 22647615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
